DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.94M	-7.71M	-7.70M	-8.62M	-9.12M	-10.04M
Depreciation and Depletion (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	0.01M	0.01M
Share-based Compensation (Quarter)	0.45M	0.30M	0.30M	0.31M	0.36M	0.42M	0.41M	0.42M	0.38M	0.42M	0.46M	0.49M	0.44M	0.56M	0.59M	0.87M	0.77M	1.02M	1.19M	0.82M
Gains from Sales and Divestitures (Quarter)											0.21M				0.28M				0.17M
Gains from Investment Securities (Quarter)	1.42M	1.47M	0.01M	0.01M	2.62M	0.99M	0.00M		0.45M	0.45M	0.00M	0.00M	4.86M	4.63M	0.00M	0.06M	6.69M	5.71M		0.00M
Non-cash Items (Quarter)		0.25M	0.02M				0.83M		3.72M	0.46M	0.83M	0.73M	1.04M	4.88M	10.24M	3.52M	3.77M	21.22M	10.60M	16.81M
Cash from Operations (Quarter)	-2.09M	-3.05M	-2.80M	-3.89M	-2.50M	-2.36M	-2.77M	-5.09M	-5.03M	-4.80M	-3.81M	-6.65M	-4.52M	-4.47M	-6.43M	-7.15M	-7.55M	-6.60M	-7.76M	-9.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.01M	-0.01M	-0.11M	-0.12M	-0.04M	0.04M	0.13M	0.20M	0.23M	0.42M	0.37M	0.33M	0.32M	0.36M	0.33M	0.26M	0.18M	0.25M	0.25M	0.19M
Depreciation & Amortization (CF) (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	0.01M	0.01M
Change in Working Capital
Change in Receivables (Quarter)	-0.32M	0.09M	0.03M	0.04M	-0.08M	-0.01M	0.01M	-0.03M	0.13M	0.12M	0.06M	0.03M	-0.01M	-0.10M	-0.05M	0.02M	-0.09M	0.10M	-0.00M	0.04M
Change in Account Payables (Quarter)	-0.45M	0.46M	-0.19M	-0.08M	0.19M	0.24M	-0.13M	1.05M	-0.92M	0.01M	0.06M	-0.21M	0.04M	0.41M	-0.23M	0.57M	-0.25M	0.66M	-0.45M	1.82M
Change in Accured Expenses (Quarter)	0.70M	-0.29M	0.09M	-0.02M	-0.09M	-0.27M	0.74M	-0.42M	0.04M	0.20M	0.53M	0.02M	0.39M	0.78M	1.30M	-1.31M	-0.33M	0.47M	0.28M	-1.23M
Other Working Capital Changes (Quarter)	0.01M	0.01M	-0.01M	0.01M	0.06M	0.06M	-0.08M		0.01M	0.05M	-0.70M	0.16M	0.30M	0.46M	-0.05M	0.42M	0.01M	0.04M	0.04M	0.25M
Investing Activities
Capital Expenditures (Quarter)	0.00M	0.00M	0.01M		0.01M	0.04M	0.03M	0.01M	0.00M	0.01M	0.00M	0.01M		0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	14.31M	9.67M	13.39M	15.59M	16.66M	10.50M	14.54M	12.34M	14.79M	13.00M	11.00M	14.00M	13.00M	16.00M	16.00M	13.50M	18.47M	9.10M	16.05M	16.79M
Cash from Investing Activities (Quarter)	0.99M	-12.83M	-8.69M	2.21M	2.53M	2.07M	4.72M	2.51M	-28.13M	1.20M	6.12M	4.21M	4.74M	-5.58M	5.21M	6.62M	8.96M	-25.77M	8.00M	-2.11M
Financing Activities
Other financing activities (Quarter)																			-0.06M
Cash from Financing Activities (Quarter)	-0.00M	29.86M	-0.02M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	36.85M	-0.01M	-0.00M	-0.00M	11.75M	0.12M	0.12M	0.09M	0.16M	31.53M	12.09M	0.42M
Additional items
Change in Cash (Quarter)	-1.10M	13.99M	-11.51M	-1.68M	0.03M	-0.29M	1.96M	-2.58M	3.69M	-3.61M	2.31M	-2.45M	11.97M	-9.93M	-1.11M	-0.44M	1.52M	-0.78M	12.32M	-10.78M
Free Cash Flow (Quarter)	-2.09M	-3.05M	-2.81M	-3.89M	-2.50M	-2.40M	-2.80M	-5.10M	-5.03M	-4.81M	-3.81M	-6.66M	-4.52M	-4.48M	-6.44M	-7.16M	-7.56M	-6.62M	-7.77M	-9.11M
Net Cash Flow (Quarter)	-1.10M	13.99M	-11.51M	-1.68M	0.03M	-0.29M	1.96M	-2.58M	3.69M	-3.61M	2.31M	-2.45M	11.97M	-9.93M	-1.11M	-0.44M	1.57M	-0.83M	12.32M	-10.80M

Research Tools

Developers

DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Research Tools

Developers

DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Create an account

Sign In

Reset Password